Vidoflufolastat (18F)

N/A

Report date: 2025/09/08 17:07:55

Base Information

Drug NameVidoflufolastat (18F)
Drug Alias NameCTT-1057-F-18CTT-1057-18F18F-CTT1057CTT-1057
ClassificationDiagnostic agent (In vivo)Small moleculesRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalySwitzerland +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesWashington UniversityCancer Targeted Technology Llc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesCancer Targeted Technology Llc
Active IndicationsProstatic Neoplasms
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A